Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease-Reference-Cited by-同舟云学术

Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease

Published:2022-05-13 Issue:1 Volume:24 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Hoursalas Athanasios¹,Tsarouhas Konstantinos²,Tsitsimpikou Christina³,Kolovou Genovefa⁴,Vardavas Alexander⁵,Hoursalas Ioannis⁶,Spandidos Demetrios⁷,Milionis Haralampos⁸,Elisaf Moses⁸,Tsiara Stavroula⁸

Affiliation:

1. Department of Pediatric Cardiology, Onasseio Cardiac Surgery Center, 17674 Athens, Greece

2. Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece

3. General Chemical State Laboratory of Greece, 11521 Athens, Greece

4. Preventive Cardiology and Lipoprotein Apheresis Unit, Metropolitan Hospital, 18547 Piraeus, Greece

5. Laboratory of Toxicology and Forensic Sciences, Faculty of Medicine, University of Crete, 71500 Heraklion, Greece

6. YGEIA Diagnostics, Private Practitioner, 20131 Korinthos, Greece

7. Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece

8. Department of Internal Medicine, Faculty of Medicine, University Hospital of Ioannina, 45110 Ioannina, Greece

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference23 articles.

1. Lipoprotein (a): An update on a marker of residual risk and associated clinical manifestations;Shah;Am J Cardiol,2020

2. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men;Seed;Am J Med,2001

3. Impact of lipoprotein(a) as residual risk on long-term outcomes in patients after percutaneous coronary intervention;Konishi;Am J Cardiol,2015

4. Studies on apolipoprotein(a) phenotypes. Part 1. Phenotype frequencies in a healthy Japanese population;Abe;Atherosclerosis,1992

5. Usefulness of lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction;Ikenaga;Circ J,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Social Determinants of Health and Lifestyle on Association Between Lipoprotein(a) and Cardiovascular Events;JACC: Advances;2024-07

2. Assessing the relationship between lipoprotein(a) levels and blood pressure among hypertensive patients beyond conventional measures. An observational study;Scientific Reports;2024-06-23

3. The Impact of Social Determinants of Health and Lifestyle on the Association of Lipoprotein(a) with Myocardial Infarction and Stroke;2023-09-03

4. Research Progress of Lipoprotein a in Cardiovascular Diseases;Advances in Clinical Medicine;2023